L2L Microarray Analysis Tool
Results for D07X.profile.u50
| Results summary | View all lists in GO:BiolProc | View all genes in D07X.profile.u50 |
| List Name | Description | Total probes |
Expected matches |
Actual matches |
Fold Enrichment |
Binomial p-value |
|---|---|---|---|---|---|---|
| regulation of actin filament length | Any process that controls the length of actin filaments in a cell. | 73 | 0.18 | 3 | 16.62 | 8.25e-04 |
| transcription from RNA polymerase II promoter | The synthesis of RNA from a DNA template by RNA polymerase II (Pol II), originating at a Pol II-specific promoter. Includes transcription of messenger RNA (mRNA) and certain small nuclear RNAs (snRNAs). | 997 | 2.46 | 9 | 3.65 | 1.01e-03 |
| response to metal ion | A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a metal ion stimulus. | 21 | 0.05 | 2 | 38.53 | 1.24e-03 |
| negative regulation of cell differentiation | Any process that stops, prevents or reduces the frequency, rate or extent of cell differentiation. | 90 | 0.22 | 3 | 13.48 | 1.51e-03 |
| organ development | Development of a tissue or tissues that work together to perform a specific function or functions. Development pertains to the process whose specific outcome is the progression of a structure over time, from its formation to the mature structure. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that work together to perform a specific function or functions. | 1733 | 4.28 | 12 | 2.80 | 1.59e-03 |
| multicellular organismal development | The biological process whose specific outcome is the progression of an organism over time from an initial condition (e.g. a zygote or a young adult) to a later condition (e.g. a multicellular animal or an aged adult). | 3036 | 7.50 | 17 | 2.27 | 1.94e-03 |
| response to inorganic substance | A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an inorganic substance stimulus. | 27 | 0.07 | 2 | 29.97 | 2.06e-03 |
| negative regulation of myeloid cell differentiation | Any process that stops, prevents or reduces the frequency, rate or extent of myeloid cell differentiation. | 27 | 0.07 | 2 | 29.97 | 2.06e-03 |
| negative regulation of developmental process | Any process that stops, prevents or reduces the rate or extent of development, the biological process whose specific outcome is the progression of an organism over time from an initial condition (e.g. a zygote, or a young adult) to a later condition (e.g. a multicellular animal or an aged adult). | 110 | 0.27 | 3 | 11.03 | 2.68e-03 |
| negative regulation of cellular process | Any process that stops, prevents or reduces the frequency, rate or extent of cellular processes, those that are carried out at the cellular level, but are not necessarily restricted to a single cell. For example, cell communication occurs among more than one cell, but occurs at the cellular level. | 1642 | 4.06 | 11 | 2.71 | 3.12e-03 |
| response to external stimulus | A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an external stimulus. | 759 | 1.88 | 7 | 3.73 | 3.17e-03 |
| circadian rhythm | The biological processes in an organism that recur with a regularity of approximately 24 hours. | 34 | 0.08 | 2 | 23.80 | 3.25e-03 |
| negative regulation of biological process | Any process that stops, prevents or reduces the frequency, rate or extent of a biological process. Biological processes are regulated by many means; examples include the control of gene expression, protein modification or interaction with a protein or substrate molecule. | 1697 | 4.19 | 11 | 2.62 | 3.98e-03 |
| negative regulation of transcription | Any process that stops, prevents or reduces the frequency, rate or extent of transcription. | 439 | 1.09 | 5 | 4.61 | 5.07e-03 |
| myeloid cell differentiation | The process whereby a relatively unspecialized myeloid precursor cell acquires the specialized features of any cell of the myeloid leukocyte, megakaryocyte, thrombocyte, or erythrocyte lineages. | 142 | 0.35 | 3 | 8.55 | 5.46e-03 |
| developmental process | A biological process whose specific outcome is the progression of an integrated living unit: a cell, tissue, organ, or organism over time from an initial condition to a later condition. | 4255 | 10.52 | 20 | 1.90 | 5.83e-03 |
| cell differentiation | The process whereby relatively unspecialized cells, e.g. embryonic or regenerative cells, acquire specialized structural and/or functional features that characterize the cells, tissues, or organs of the mature organism or some other relatively stable phase of the organism's life history. Differentiation includes the processes involved in commitment of a cell to a specific fate. | 2359 | 5.83 | 13 | 2.23 | 7.01e-03 |
| cellular developmental process | A biological process whose specific outcome is the progression of a cell over time from an initial condition to a later condition. | 2359 | 5.83 | 13 | 2.23 | 7.01e-03 |
| hemopoiesis | The process whose specific outcome is the progression of the myeloid and lymphoid derived organ/tissue systems of the blood and other parts of the body over time, from formation to the mature structure. The site of hemopoiesis is variable during development, but occurs primarily in bone marrow or kidney in many adult vertebrates. | 303 | 0.75 | 4 | 5.34 | 7.17e-03 |
| insulin receptor signaling pathway | The series of molecular signals generated as a consequence of the insulin receptor binding to insulin. | 51 | 0.13 | 2 | 15.86 | 7.19e-03 |
| negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process | Any process that stops, prevents or reduces the frequency, rate or extent of the chemical reactions and pathways involving nucleobases, nucleosides, nucleotides and nucleic acids. | 478 | 1.18 | 5 | 4.23 | 7.19e-03 |
| actin cytoskeleton organization and biogenesis | A process that is carried out at the cellular level which results in the formation, arrangement of constituent parts, or disassembly of cytoskeletal structures comprising actin filaments and their associated proteins. | 313 | 0.77 | 4 | 5.17 | 8.01e-03 |
| erythrocyte differentiation | The process by which a myeloid precursor cell acquires specializes features of an erythrocyte. | 54 | 0.13 | 2 | 14.98 | 8.03e-03 |
| regulation of transcription from RNA polymerase II promoter | Any process that modulates the frequency, rate or extent of transcription from an RNA polymerase II promoter. | 701 | 1.73 | 6 | 3.46 | 8.64e-03 |
| cell death | The specific activation or halting of processes within a cell so that its vital functions markedly cease, rather than simply deteriorating gradually over time, which culminates in cell death. | 1152 | 2.85 | 8 | 2.81 | 8.85e-03 |
| death | A permanent cessation of all vital functions: the end of life; can be applied to a whole organism or to a part of an organism. | 1152 | 2.85 | 8 | 2.81 | 8.85e-03 |
| B cell differentiation | The process whereby a relatively unspecialized hemopoietic stem cell acquires the specialized features of a B cell. | 57 | 0.14 | 2 | 14.19 | 8.91e-03 |
| hemopoietic or lymphoid organ development | The process whose specific outcome is the progression of any organ involved in hemopoiesis or lymphoid cell activation over time, from its formation to the mature structure. Such development includes differentiation of resident cell types (stromal cells) and of migratory cell types dependent on the unique microenvironment afforded by the organ for their proper differentiation. | 323 | 0.80 | 4 | 5.01 | 8.92e-03 |
| cell proliferation | The multiplication or reproduction of cells, resulting in the rapid expansion of a cell population. | 1154 | 2.85 | 8 | 2.80 | 8.93e-03 |